{"organizations": [], "uuid": "8cbecd0d4c8de8459cf95c5613b77f87b6cdd5e3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180124.html", "section_title": "Archive News &amp; Video for Wednesday, 24 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-shire-says-fda-approves-technology/brief-shire-says-fda-approves-technology-transfer-of-cinryze-manufacturing-process-to-vienna-idUSFWN1PJ0LD", "country": "US", "domain_rank": 408, "title": "BRIEF-Shire says FDA Approves Technology Transfer Of Cinryze Manufacturing Process To Vienna", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.07, "site_type": "news", "published": "2018-01-24T19:03:00.000+02:00", "replies_count": 0, "uuid": "8cbecd0d4c8de8459cf95c5613b77f87b6cdd5e3"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-shire-says-fda-approves-technology/brief-shire-says-fda-approves-technology-transfer-of-cinryze-manufacturing-process-to-vienna-idUSFWN1PJ0LD", "ord_in_thread": 0, "title": "BRIEF-Shire says FDA Approves Technology Transfer Of Cinryze Manufacturing Process To Vienna", "locations": [], "entities": {"persons": [], "locations": [{"name": "vienna", "sentiment": "none"}, {"name": "vienna", "sentiment": "none"}, {"name": "austria", "sentiment": "none"}], "organizations": [{"name": "brief-shire", "sentiment": "negative"}, {"name": "shire plc", "sentiment": "negative"}, {"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 24 (Reuters) - Shire Plc:\n* FDA GRANTS APPROVAL TO SHIRE FOR TECHNOLOGY TRANSFER OF CINRYZE® DRUG PRODUCT MANUFACTURING PROCESS TO VIENNA, AUSTRIA MANUFACTURING SITE\n* ‍SHIRE WILL BEGIN COMMERCIAL MANUFACTURING OF CINRYZE DRUG PRODUCT IN VIENNA IN Q1 OF 2018​\n* ‍CINRYZE WILL ALSO CONTINUE TO BE PRODUCED BY A THIRD-PARTY SUPPLIER, PROVIDING AN ADDITIONAL SUPPLY SOURCE TO MEET PATIENT DEMAND.​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-24T19:03:00.000+02:00", "crawled": "2018-01-25T13:05:23.008+02:00", "highlightTitle": ""}